Prevalence, Location, and Determinants of Valvular Calcifications in Congolese Patients on Chronic Hemodialysis: A

Yannick M Engole1, Yves N Lubenga2, Yannick M Nlandu1

  • 1Nephrology Unit, University Hospital of Kinshasa, Kinshasa, Democratic Republic of Congo.

Insights

Valvular calcifications are common in Congolese hemodialysis patients. Hypertension, older age, smoking, and high phosphorus levels are key risk factors for this cardiovascular complication.

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health

Background:

  • Valvular calcifications (VCs) are a significant cardiovascular complication in patients undergoing chronic hemodialysis (HD).
  • VCs contribute to increased morbidity and mortality in this vulnerable population.
  • Understanding the prevalence and risk factors of VCs in specific demographics, like Congolese HD patients, is crucial.

Purpose of the Study:

  • To determine the prevalence and location of valvular calcifications (VCs) in Congolese patients on chronic hemodialysis (HD).
  • To identify traditional and chronic kidney disease-specific risk factors associated with VCs in this patient group.
  • To provide insights into cardiovascular health management for HD patients in Kinshasa.

Main Methods:

  • An observational study was conducted across three HD centers in Kinshasa from March to August 2016.
  • Sixty adult patients on maintenance HD for at least six months were recruited.
  • Valvular calcifications were diagnosed via echocardiography, and risk factors were analyzed using multivariate analysis.

Main Results:

  • Valvular calcifications were present in 38% of the studied patients.
  • The most common locations for VCs were the aortic valve (64%) and mitral valve (23%).
  • Independent risk factors identified included hypertension, age over 60, tobacco use, and hyperphosphatemia.

Conclusions:

  • Valvular calcifications are a frequent finding in Congolese chronic HD patients, even at a relatively young age.
  • The study highlights the association of VCs with both traditional cardiovascular risk factors and chronic kidney disease-specific factors like hyperphosphatemia.
  • These findings underscore the need for targeted screening and management of VCs in HD populations in sub-Saharan Africa.

Related Concept Videos

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
229
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
334
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
370
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
232
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
261
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
252